Stay updated on Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record for a Phase I trial combining fostamatinib and paclitaxel is displayed, with details on the trial plan, participant criteria, locations, outcome measures, and record history. It also includes posted study documents and results-related information.
    Difference
    57%
    Check dated 2026-11-09T13:56:43.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site revision label updates from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:50:42.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A banner announces that NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during a terminology transition.
    Difference
    1%
    Check dated 2026-10-26T15:22:00.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-19T14:54:52.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T15:51:53.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A 403 Forbidden error page has been added, displaying a 403 message with an error header and a Home link. This indicates that access to the study record is blocked.
    Difference
    0.5%
    Check dated 2026-09-28T19:23:25.000Z thumbnail image

Stay in the know with updates to Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.